This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Medizinische Universitat Wien, Polymun Scientific Immunbiologische Forschung Gmbh, Universitat Fur Bodenkultur Wien. Active years: 2007-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2026
Title: Innovations and Contributions of Johannes Grillari
Introduction
Johannes Grillari is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of biomedical research, particularly in the area of cell regulation and senescence. With a total of 2 patents, his work has implications for medical diagnostics and therapeutic applications.
Latest Patents
Grillari's latest patents include innovative compositions aimed at eliminating senescent cells. One patent focuses on a composition that comprises inhibitors capable of inhibiting cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), and lipoxygenase. This invention also includes methods for identifying senescent cells and candidate compounds for their selective elimination. Another patent relates to cell-regulatory proteins and nucleotide sequences that serve as potential tumor and senescence markers. These proteins have therapeutic potential and antiapoptotic properties, which can improve cell viability in culture technology.
Career Highlights
Throughout his career, Johannes Grillari has worked with prominent organizations such as Polymun Scientific Immunbiologische Forschung GmbH and Universität für Bodenkultur Wien. His research has contributed to advancements in understanding cell behavior and its implications for health and disease.
Collaborations
Grillari has collaborated with esteemed colleagues, including Hermann W. Katinger and Reingard Grabherr. These partnerships have fostered a collaborative environment that enhances the impact of their research.
Conclusion
Johannes Grillari's innovative work in the field of biomedical research highlights his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving health outcomes through scientific discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile